Agree, it would certainly take days for full effect.
* It took 3-4 days for share price reaching its highest (from $0.135 to $0.175) after Antimicrobial Data Published in UQ and Peer-Reviewed Journal.
* The short sellers would try to recover the remaining 3 millions short selling in the lower prices.
* Vine would have presented those Top-Line Data of BTX 1801 2a Clinical Study Results with Big Pharma (eg Pfizer etc). Watch this space for TO.
* Professor Geoffrey Coombs, Murdoch University’s Chair of Public Health, commented: "Data from the BTX 1801 study represents a significant milestone and enhances the potential of better infection prevention measuresin surgical settings to combat the growing global development of antibiotic resistance"
* The UN forecasting that drug resistant diseases could cause 10 million deaths each year by 2050 and result in an annual economic loss of US$100 trillion if new solutions are not found.
- Forums
- ASX - By Stock
- BOT
- Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus, page-233
-
- There are more pages in this discussion • 768 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
34.5¢ |
Change
-0.020(5.48%) |
Mkt cap ! $543.4M |
Open | High | Low | Value | Volume |
35.5¢ | 35.5¢ | 34.0¢ | $4.566M | 13.13M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 410003 | 34.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.0¢ | 346713 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 403003 | 0.345 |
16 | 304864 | 0.340 |
12 | 887560 | 0.335 |
25 | 2286069 | 0.330 |
5 | 853843 | 0.325 |
Price($) | Vol. | No. |
---|---|---|
0.350 | 346713 | 8 |
0.355 | 48198 | 4 |
0.360 | 261992 | 7 |
0.365 | 522058 | 4 |
0.370 | 319527 | 7 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online